![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Susanne Hartman
susanne.hartman@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine
Caption: Pictured is a cholesterol-filled atherosclerotic coronary artery from a human body. Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. A new study shows that targeted inhibition of the microsomal triglyceride transfer protein (MTP) is highly effective in reducing cholesterol levels in very high risk patients.
Credit: Courtesy: University of Pennsylvania School of Medicine
Usage Restrictions: None
Related news release: Penn researchers demonstrate ability of new therapy to treat severely elevated cholesterol levels
|